Royalty Pharma plc (RPRX) Operating cash flow 2018–2025
Royalty Pharma plc (RPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.5BFY2025 · since FY2018: $1.6B → $2.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5B | -10.1% |
| FY2024 | $2.8B | -7.3% |
| FY2023 | $3.0B | +39.4% |
| FY2022 | $2.1B | +6.3% |
| FY2021 | $2.0B | -0.8% |
| FY2020 | $2.0B | +22.0% |
| FY2019 | $1.7B | +3.0% |
| FY2018 | $1.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice